About Us

At Charles River Singapore, we understand your need to deliver safe and effective products into the market in the shortest time possible. We are constantly forging ahead in being a focal point in the Asia Pacific region as a market leader and in providing top-notch regulatory and validation services to our clients. Starting out in 1997 as a provider of customized microbiological and safety assessment services to the medical devices industry, BRASS Pte Ltd ("BRASS") was fully acquired by Charles River Laboratories International, Inc., on 4th October 2013 and is now fully integrated into the Charles River family. Charles River Singapore is a key provider of top-notch specialized microbiological services and state-of-the-art products for microbial detection and identification for biopharmaceutical, medical device and life sciences manufacturing. Our ultimate goal is to provide accurate, efficient and value-add product and services to ensure safe manufacturing and timely release of clients' products to the market. Charles River Singapore will add to Charles River's presence in Asia, which already includes sites in Korea, India and China.  

Click here for our A2LA  Certificate of Accreditation